Features

Here’s a quick look at some of the biggest movers of the week:

Drug trial results remained the important theme over the past week with several companies announcing key study results. Here’s a quick look at...

Cancer drugs are less affordable in low-income countries, despite the lower retail prices, according to a study released at the annual ASCO meet...

There may not have been many eye-popping moments, but there’s still plenty to dissect following the 52nd ASCO congress

Here’s a quick look at some of the biggest movers of the week:

Bayer-Monsanto story comes close on the heels of Sanofi-Medivation tussle as the pharma sector goes through the motions of consolidation

Maintaining that a stringent and complex regulatory process is a must to maintain the quality thresholds, the regulators offer ideas to tackle the...

The earnings season came to a close with Germany’s Merck doubling its first-quarter profits. For the week, drug trials, analyst comments and deals...

We have hit the tail end of the earnings season and the near last batch of movers follow result pronouncements by companies

Lawmakers across continents mull action to contain the rapid price hikes for existing and new drugs